Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications. ODTs differ from traditional tablets in that they are designed to be dissolved on the tongue rather than swallowed whole. The ODT serves as an alternative dosage form for patients who experience dysphagia (difficulty in swallowing) or for where compliance is a known issue and therefore an easier dosage form to take ensures that medication is taken.
The classification of Orally Disintegrating Tablet includes Anti-Psychotics Drug, Anti-Epileptics Drug and others, and the proportion of Anti-Psychotics Drug in 2017 is about 16.6%, Anti-Psychotics drug class will be the reigning segment in terms of market revenue share throughout the forecast period, anticipated to hold about 20.3% revenue share of the global market by 2025 end. With a noteworthy 15.7% CAGR, this segment will retain its supremacy over other drug class segments during the eight-year period. Under by Disease Indication, the global market is segmented into Central Nervous System (CNS) Diseases, Gastrointestinal (GI) Diseases, Cardiovascular (CVS) Diseases and Others. CNS Diseases segment will hold maximum revenue share in the global market, and the consumption proportion is about 53.4% in 2017. and forecasts indicate a 57.2% market share for this segment by the end of the forecast period in 2025.North America is the largest consumption place, with a consumption market share nearly 40.5% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 31.6%, China is also an important sales region for the Orally Disintegrating Tablet.
The report details the trend, potential and market size of Orally Disintegrating Tablet market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Orally Disintegrating Tabletmarket, defines the market attractiveness level of Orally Disintegrating Tablet market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Orally Disintegrating Tablet industry, describes the types of Orally Disintegrating Tablet market, the applications of major players and the market size, and deeply analyzes the current situation of the global Orally Disintegrating Tablet market and the development prospects and opportunities of Orally Disintegrating Tablet industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Orally Disintegrating Tablet market in Chapter 13.
By Player:
Pfizer
GSK
Bristol-Myers Squibb
Conquer
Otsuka
AstraZeneca
Johnson and Johnson
Teva
Eli Lilly and Company
Mylan
Merck
By Type:
Anti-psychotics Drug
Anti-epileptics Drug
Other
By End-User:
CNS Diseases
Gastrointestinal Diseases
CVS Diseases
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Orally Disintegrating Tablet Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Orally Disintegrating Tablet Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Orally Disintegrating Tablet Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Orally Disintegrating Tablet Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Orally Disintegrating Tablet Market Analysis and Outlook to 2022
-
7.1 Global Orally Disintegrating Tablet Consumption (2017-2022)
-
7.2 United States Orally Disintegrating Tablet Consumption (2017-2022)
-
7.3 Europe Orally Disintegrating Tablet Consumption (2017-2022)
-
7.4 China Orally Disintegrating Tablet Consumption (2017-2022)
-
7.5 Japan Orally Disintegrating Tablet Consumption (2017-2022)
-
7.6 India Orally Disintegrating Tablet Consumption (2017-2022)
-
7.7 South Korea Orally Disintegrating Tablet Consumption (2017-2022)
8 Region and Country-wise Orally Disintegrating Tablet Market Analysis and Outlook to 2028
-
8.1 Global Orally Disintegrating Tablet Consumption Forecast (2022-2028)
-
8.2 United States Orally Disintegrating Tablet Consumption Forecast (2022-2028)
-
8.3 Europe Orally Disintegrating Tablet Consumption Forecast (2022-2028)
-
8.4 China Orally Disintegrating Tablet Consumption Forecast (2022-2028)
-
8.5 Japan Orally Disintegrating Tablet Consumption Forecast (2022-2028)
-
8.6 India Orally Disintegrating Tablet Consumption Forecast (2022-2028)
-
8.7 South Korea Orally Disintegrating Tablet Consumption Forecast (2022-2028)
9 Global Orally Disintegrating Tablet Market Outlook by Types and Applications to 2022
-
9.1 Global Orally Disintegrating Tablet Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Anti-psychotics Drug Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Anti-epileptics Drug Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global Orally Disintegrating Tablet Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global CNS Diseases Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Gastrointestinal Diseases Consumption and Growth Rate (2017-2022)
-
9.2.3 Global CVS Diseases Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Other Consumption and Growth Rate (2017-2022)
10 Global Orally Disintegrating Tablet Market Outlook by Types and Applications to 2028
-
10.1 Global Orally Disintegrating Tablet Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Anti-psychotics Drug Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Anti-epileptics Drug Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Orally Disintegrating Tablet Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global CNS Diseases Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Gastrointestinal Diseases Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global CVS Diseases Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Orally Disintegrating Tablet Import and Export Analysis (Top 5 Countries)
-
11.1 Global Orally Disintegrating Tablet Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Orally Disintegrating Tablet Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Orally Disintegrating Tablet Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Orally Disintegrating Tablet Market Competitive Analysis
-
14.1 Pfizer
-
14.1.1 Pfizer Company Details
-
14.1.2 Pfizer Orally Disintegrating Tablet Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Pfizer Orally Disintegrating Tablet Product and Service
-
14.2 GSK
-
14.2.1 GSK Company Details
-
14.2.2 GSK Orally Disintegrating Tablet Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 GSK Orally Disintegrating Tablet Product and Service
-
14.3 Bristol-Myers Squibb
-
14.3.1 Bristol-Myers Squibb Company Details
-
14.3.2 Bristol-Myers Squibb Orally Disintegrating Tablet Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Bristol-Myers Squibb Orally Disintegrating Tablet Product and Service
-
14.4 Conquer
-
14.4.1 Conquer Company Details
-
14.4.2 Conquer Orally Disintegrating Tablet Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Conquer Orally Disintegrating Tablet Product and Service
-
14.5 Otsuka
-
14.5.1 Otsuka Company Details
-
14.5.2 Otsuka Orally Disintegrating Tablet Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Otsuka Orally Disintegrating Tablet Product and Service
-
14.6 AstraZeneca
-
14.6.1 AstraZeneca Company Details
-
14.6.2 AstraZeneca Orally Disintegrating Tablet Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 AstraZeneca Orally Disintegrating Tablet Product and Service
-
14.7 Johnson and Johnson
-
14.7.1 Johnson and Johnson Company Details
-
14.7.2 Johnson and Johnson Orally Disintegrating Tablet Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Johnson and Johnson Orally Disintegrating Tablet Product and Service
-
14.8 Teva
-
14.8.1 Teva Company Details
-
14.8.2 Teva Orally Disintegrating Tablet Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Teva Orally Disintegrating Tablet Product and Service
-
14.9 Eli Lilly and Company
-
14.9.1 Eli Lilly and Company Company Details
-
14.9.2 Eli Lilly and Company Orally Disintegrating Tablet Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Eli Lilly and Company Orally Disintegrating Tablet Product and Service
-
14.10 Mylan
-
14.10.1 Mylan Company Details
-
14.10.2 Mylan Orally Disintegrating Tablet Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Mylan Orally Disintegrating Tablet Product and Service
-
14.11 Merck
-
14.11.1 Merck Company Details
-
14.11.2 Merck Orally Disintegrating Tablet Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Merck Orally Disintegrating Tablet Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Orally Disintegrating Tablet
-
Figure Orally Disintegrating Tablet Picture
-
Table Global Orally Disintegrating Tablet Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Orally Disintegrating Tablet Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Orally Disintegrating Tablet Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Orally Disintegrating Tablet Consumption by Country (2017-2022)
-
Figure United States Orally Disintegrating Tablet Consumption and Growth Rate (2017-2022)
-
Table Europe Orally Disintegrating Tablet Consumption and Growth Rate (2017-2022)
-
Figure China Orally Disintegrating Tablet Consumption and Growth Rate (2017-2022)
-
Figure Japan Orally Disintegrating Tablet Consumption and Growth Rate (2017-2022)
-
Figure India Orally Disintegrating Tablet Consumption and Growth Rate (2017-2022)
-
Figure South Korea Orally Disintegrating Tablet Consumption and Growth Rate (2017-2022)
-
Figure Global Orally Disintegrating Tablet Consumption Forecast by Country (2022-2028)
-
Figure United States Orally Disintegrating Tablet Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Orally Disintegrating Tablet Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Orally Disintegrating Tablet Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Orally Disintegrating Tablet Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Orally Disintegrating Tablet Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Orally Disintegrating Tablet Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Anti-psychotics Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Anti-epileptics Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global CNS Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Gastrointestinal Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global CVS Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Anti-psychotics Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Anti-epileptics Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global CNS Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Gastrointestinal Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global CVS Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Orally Disintegrating Tablet Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Orally Disintegrating Tablet Export by Region (Top 5 Countries) (2017-2028)
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Orally Disintegrating Tablet Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Orally Disintegrating Tablet Product and Service
-
Table GSK (Foundation Year, Company Profile and etc.)
-
Table GSK Orally Disintegrating Tablet Sales, Price, Value and Gross Profit (2017-2022)
-
Table GSK Orally Disintegrating Tablet Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Orally Disintegrating Tablet Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Orally Disintegrating Tablet Product and Service
-
Table Conquer (Foundation Year, Company Profile and etc.)
-
Table Conquer Orally Disintegrating Tablet Sales, Price, Value and Gross Profit (2017-2022)
-
Table Conquer Orally Disintegrating Tablet Product and Service
-
Table Otsuka (Foundation Year, Company Profile and etc.)
-
Table Otsuka Orally Disintegrating Tablet Sales, Price, Value and Gross Profit (2017-2022)
-
Table Otsuka Orally Disintegrating Tablet Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Orally Disintegrating Tablet Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Orally Disintegrating Tablet Product and Service
-
Table Johnson and Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson and Johnson Orally Disintegrating Tablet Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson and Johnson Orally Disintegrating Tablet Product and Service
-
Table Teva (Foundation Year, Company Profile and etc.)
-
Table Teva Orally Disintegrating Tablet Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Orally Disintegrating Tablet Product and Service
-
Table Eli Lilly and Company (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly and Company Orally Disintegrating Tablet Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly and Company Orally Disintegrating Tablet Product and Service
-
Table Mylan (Foundation Year, Company Profile and etc.)
-
Table Mylan Orally Disintegrating Tablet Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mylan Orally Disintegrating Tablet Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Orally Disintegrating Tablet Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Orally Disintegrating Tablet Product and Service
-
